Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

News zum Sektor Bau aus Europa

Zum Sektor Bau gehören alle Unternehmen, welche Gebäude, Straßen, Brücken und andere Infrastrukturprojekte bauen, renovieren, instandhalten oder abreißen. Hersteller von Baumaterialien und Baumaschinen gehören auch zum Sektor, sofern sie überwiegend für die Baubranche produzieren.
 >Bau ETFs & Fonds 
Es sind 6 ETFs & Fonds zum Sektor Bau bekannt.
 >Aktien zum Sektor Bau 
Es sind 454 Aktien zum Sektor Bau bekannt.
 
16.11.25 - 09:48
9% yield! But is a huge dividend a big problem for this FTSE 250 stock? (Fool)
 
Taylor Wimpey was relegated to the FTSE 250 earlier this year. And Stephen Wright thinks a consistent dividend might be a big part of the reason why. The post 9% yield! But is a huge dividend a big problem for this FTSE 250 stock? appeared first on The Motley Fool UK....
16.11.25 - 08:12
Britain′s biggest housebuilder urges government to support first-time buyers (The Guardian)
 
Taylor Wimpey chief Jennie Daly calls for revival of help-to-buy equity loan scheme to revive property marketThe boss of one of Britain's biggest housebuilders has urged the government to announce more support for first-time buyers to revive a property market that has cooled in the “very long shadow” of the looming budget.Jennie Daly, the chief executive of Taylor Wimpey, also warned against an “accumulation of regulation”, arguing that a “perverse outcome” of green measures could be that it becomes unviable to build new homes in poorer areas of the country. Continue reading......
15.11.25 - 16:06
Epiroc launches next-generation PCD drill bits (Mining.com)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
15.11.25 - 04:39
James Hardie Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against James Hardie Industries plc - JHX (PR Newswire)
 
NEW ORLEANS, Nov. 14, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have untilDecember 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against James Hardie Industries plc ("James Hardie" or the......
15.11.25 - 00:00
Soros Capital adds Vimeo, exits Titan America, among Q3 trades (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.11.25 - 21:30
Zurich selects Arrowsight to help transform on-site construction safety across the U.S. with proven camera-enabled coaching solution (PR Newswire)
 
Workers' Comp claim frequency dropped over 50% in 3-year NYC pilot of Arrowsight; top contractors Skanska, Suffolk, Gilbane, Posillico and Tutor Perini attest that video analytics and coaching significantly enhance jobsite safety. SCHAUMBURG, Ill., Nov. 14, 2025 /PRNewswire/ -- Zurich......
14.11.25 - 18:03
James Hardie Industries plc (JHX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., Nov. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX). IF YOU ARE......
14.11.25 - 17:54
ANALYSE-FLASH: Jefferies lässt Heidelberg Materials auf ′Buy′ - Ziel 245,20 Euro (DPA-AFX)
 
NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat Heidelberg Materials auf "Buy" mit einem Kursziel von 245,20 Euro belassen. Der Baustoffkonzern habe die Fixkosten im laufenden Jahr gesenkt und sehe weitere ......
14.11.25 - 17:42
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy (Benzinga)
 
Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026. Latest Ratings for BMY DateFirmActionFromTo Mar 2022Wells FargoMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnBuy Dec 2021Wells FargoInitiates Coverage OnEqual-Weight View More Analyst Ratings for BMY View the Latest Analyst Ratings read more...
14.11.25 - 17:36
Heidelberg Materials Buy (DPA-AFX)
 
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Heidelberg Materials auf "Buy" mit einem Kursziel von 245,20 Euro belassen. Der Baustoffkonzern habe die Fixkosten im laufenden Jahr gesenkt und sehe weitere Einsparmöglichkeiten durch Digitalisierung ......
14.11.25 - 16:24
HEXAOM : 2025 NINE-MONTH REVENUE EUR 442.9 MILLION IN LINE WITH ANNUAL TARGETS (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
14.11.25 - 16:06
Milliarden für Rechenzentren: Der Daten-Deal des Jahres: ACS und BlackRock starten ein Mega-Projekt! (Wallstreet-Online)
 
ACS und BlackRock bauen ein globales Netzwerk neuer Rechenzentren. Der Milliarden-Pakt soll den wachsenden Hunger nach KI- und Cloudpower stillen.Jetzt den vollständigen Artikel lesen...
14.11.25 - 15:57
JHX DEADLINE: Faruqi & Faruqi Reminds James Hardie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 23, 2025 - JHX (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in James Hardie between May 20, 2025 and August 18, 2025 and would like......
14.11.25 - 15:12
Marshalls makes bold change to return policy ahead of holidays (The Street)
 
Marshalls has quietly provided shoppers with new return policy guidelines....
14.11.25 - 15:06
Bristol Myers Squibb, J&J Discontinue Phase 3 Librexia ACS Study Of Milvexian After Interim Review (AFX)
 
NEW BRUNSWICK (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) on Friday said it has halted the Phase 3 Librexia ACS trial of milvexian, conducted in partnership with Johnson & Johnson (JNJ), in patient......
14.11.25 - 15:03
Levi & Korsinsky Reminds James Hardie Industries plc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 23, 2025 - JHX (PR Newswire)
 
NEW YORK, Nov. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. ("James Hardie Industries plc." or the "Company") (NYSE: JHX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of James......
14.11.25 - 14:36
NRC Group ASA – Cancellation of contract (NOK 32 million) in Norway (Cision)
 
Reference is made to announcement of 23 October 2025, in which it was informed that NRC Norge AS (NRC) was appointed to a civil contract with Nordreisa Municipality covering ground, foundation and construction work. NRC has today received notice from Nordreisa Municipality that the contract has been cancelled due to the lack of necessary financing. For further information, please contact: Åsgeir Nord, CFO of NRC Group, + 47 957 34 985. This information is considered to be inside information pursuant to the EU Market Abuse Regulation, and is subject to the disclosure requirements...
14.11.25 - 14:30
Bristol Myers Squibb: Studienrückschlag – Erinnerungen an Bayer werden wach (Der Aktionaer)
 
Der US-amerikanische Pharma-Riese muss einen weiteren Forschungsrückschlag hinnehmen. Die sogenannte Librexia-ACS-Studie, die den Wirkstoff Milvexian als Ergänzung zur Standardtherapie (konventionelle Thrombozytenaggregationshemmung) bei Patienten nach einem kürzlich aufgetretenen akuten Koronarsyndrom (ACS) untersucht, wird eingestellt....
14.11.25 - 13:18
DIRECTOR DEALINGS: Springfield Properties chair banks PS2.6 million (Alliance)
 
The following is a round-up of share dealings by London-listed company directors and managers announced this week and not...
14.11.25 - 12:57
ACS, BlackRock′s GlP to launch €2B data center joint venture (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gesetze, Zeiten, Völker überleben sich. Nur die Sternbilder der Kunst schimmern in alter Unvergänglichkeit über den Kirchhöfen der Zeit. - Jean Paul
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!